Court Rejects PTO Rule, Says “Substantive” Changes Only By Congress
This article was originally published in The Tan Sheet
Executive Summary
The U.S. Patent and Trademark Office overstepped its authority in issuing rules to limit certain patent filings, a federal judge says in a ruling that declares those rules null and void
You may also be interested in...
Small Supplement Firms Among Most Affected By Proposed PTO Change
Dietary supplement firms fall within the industry segment that, according to the U.S. Patent and Trademark Office, most frequently employs a patent application strategy the agency proposes to limit
Senators Oppose Patent Reform Provisions; GSK Also Urges Revisions To Bill
As patent reform legislation heads toward the Senate floor, members of the biotech and pharmaceutical industries are imploring legislators to alter key provisions. And a group of Senators is criticizing the bill's formulation for apportioning damage awards in infringement suits
Companies Reveal Hurdles In Providing Drugs Via Expanded Access Programs
GSK, Stealth BioTherapeutics and Blueprint Medicines discuss the difficulties getting participation of physicians, the excessive cost of expanded access, and whether physicians should report research data.